SARS-CoV-2 Infection and Guillain-Barré Syndrome
Severe acute respiratory syndrome coronavirus strain 2 (SARS-CoV-2) is a beta-coronavirus that emerged as a global threat and caused a pandemic following its first outbreak in Wuhan, China, in late 2019. SARS-CoV-2 causes COVID-19, a disease ranging from relatively mild to severe illness. Older peop...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2021-07-01
|
| Series: | Pathogens |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2076-0817/10/8/936 |
| _version_ | 1797522497279623168 |
|---|---|
| author | Huda Makhluf Henry Madany |
| author_facet | Huda Makhluf Henry Madany |
| author_sort | Huda Makhluf |
| collection | DOAJ |
| description | Severe acute respiratory syndrome coronavirus strain 2 (SARS-CoV-2) is a beta-coronavirus that emerged as a global threat and caused a pandemic following its first outbreak in Wuhan, China, in late 2019. SARS-CoV-2 causes COVID-19, a disease ranging from relatively mild to severe illness. Older people and those with many serious underlying medical conditions such as diabetes, heart or lung conditions are at higher risk for developing severe complications from COVID-19 illness. SARS-CoV-2 infections of adults can lead to neurological complications ranging from headaches, loss of taste and smell, to Guillain–Barré syndrome, an autoimmune disease characterized by neurological deficits. Herein we attempt to describe the neurological manifestations of SARS-CoV2 infection with a special focus on Guillain-Barré syndrome. |
| first_indexed | 2024-03-10T08:30:14Z |
| format | Article |
| id | doaj.art-65ed3ded2c924feb85aa1b2d05a26ca6 |
| institution | Directory Open Access Journal |
| issn | 2076-0817 |
| language | English |
| last_indexed | 2024-03-10T08:30:14Z |
| publishDate | 2021-07-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Pathogens |
| spelling | doaj.art-65ed3ded2c924feb85aa1b2d05a26ca62023-11-22T09:08:15ZengMDPI AGPathogens2076-08172021-07-0110893610.3390/pathogens10080936SARS-CoV-2 Infection and Guillain-Barré SyndromeHuda Makhluf0Henry Madany1Department of Mathematics and Natural Sciences, National University, La Jolla, CA 92037, USAPublic Health, University of California, Irvine, CA 92697, USASevere acute respiratory syndrome coronavirus strain 2 (SARS-CoV-2) is a beta-coronavirus that emerged as a global threat and caused a pandemic following its first outbreak in Wuhan, China, in late 2019. SARS-CoV-2 causes COVID-19, a disease ranging from relatively mild to severe illness. Older people and those with many serious underlying medical conditions such as diabetes, heart or lung conditions are at higher risk for developing severe complications from COVID-19 illness. SARS-CoV-2 infections of adults can lead to neurological complications ranging from headaches, loss of taste and smell, to Guillain–Barré syndrome, an autoimmune disease characterized by neurological deficits. Herein we attempt to describe the neurological manifestations of SARS-CoV2 infection with a special focus on Guillain-Barré syndrome.https://www.mdpi.com/2076-0817/10/8/936SARS-CoV-2COVID-19Guillain-Barré Syndrome |
| spellingShingle | Huda Makhluf Henry Madany SARS-CoV-2 Infection and Guillain-Barré Syndrome Pathogens SARS-CoV-2 COVID-19 Guillain-Barré Syndrome |
| title | SARS-CoV-2 Infection and Guillain-Barré Syndrome |
| title_full | SARS-CoV-2 Infection and Guillain-Barré Syndrome |
| title_fullStr | SARS-CoV-2 Infection and Guillain-Barré Syndrome |
| title_full_unstemmed | SARS-CoV-2 Infection and Guillain-Barré Syndrome |
| title_short | SARS-CoV-2 Infection and Guillain-Barré Syndrome |
| title_sort | sars cov 2 infection and guillain barre syndrome |
| topic | SARS-CoV-2 COVID-19 Guillain-Barré Syndrome |
| url | https://www.mdpi.com/2076-0817/10/8/936 |
| work_keys_str_mv | AT hudamakhluf sarscov2infectionandguillainbarresyndrome AT henrymadany sarscov2infectionandguillainbarresyndrome |